These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30783994)

  • 1. Dendritic cells and Brucella spp. interaction: the sentinel host and the stealthy pathogen.
    Avila-Calderón ED; Flores-Romo L; Sharon W; Donis-Maturano L; Becerril-García MA; Arreola MGA; Reynoso BA; Güemes FS; Contreras-Rodríguez A
    Folia Microbiol (Praha); 2020 Feb; 65(1):1-16. PubMed ID: 30783994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brucella discriminates between mouse dendritic cell subsets upon in vitro infection.
    Papadopoulos A; Gagnaire A; Degos C; de Chastellier C; Gorvel JP
    Virulence; 2016; 7(1):33-44. PubMed ID: 26606688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ microscopy analysis reveals local innate immune response developed around Brucella infected cells in resistant and susceptible mice.
    Copin R; Vitry MA; Hanot Mambres D; Machelart A; De Trez C; Vanderwinden JM; Magez S; Akira S; Ryffel B; Carlier Y; Letesson JJ; Muraille E
    PLoS Pathog; 2012; 8(3):e1002575. PubMed ID: 22479178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brucella spp. Virulence Factors and Immunity.
    Byndloss MX; Tsolis RM
    Annu Rev Anim Biosci; 2016; 4():111-27. PubMed ID: 26734887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of Chronic Infection: Brucella's Stealth Strategy.
    Ahmed W; Zheng K; Liu ZF
    Front Cell Infect Microbiol; 2016; 6():30. PubMed ID: 27014640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immune encounters of the (Type) 4th kind: Brucella.
    de Jong MF; Rolán HG; Tsolis RM
    Cell Microbiol; 2010 Sep; 12(9):1195-202. PubMed ID: 20670294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The innate immune response against Brucella in humans.
    Dornand J; Gross A; Lafont V; Liautard J; Oliaro J; Liautard JP
    Vet Microbiol; 2002 Dec; 90(1-4):383-94. PubMed ID: 12414158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important biology events and pathways in Brucella infection and implications for novel antibiotic drug targets.
    Gao G; Xu J
    Crit Rev Eukaryot Gene Expr; 2013; 23(1):65-76. PubMed ID: 23557338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evolutionary strategy for a stealthy intracellular Brucella pathogen.
    Martirosyan A; Moreno E; Gorvel JP
    Immunol Rev; 2011 Mar; 240(1):211-34. PubMed ID: 21349096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.
    de Figueiredo P; Ficht TA; Rice-Ficht A; Rossetti CA; Adams LG
    Am J Pathol; 2015 Jun; 185(6):1505-17. PubMed ID: 25892682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion.
    Billard E; Dornand J; Gross A
    Infect Immun; 2007 Oct; 75(10):4980-9. PubMed ID: 17635859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Neutrophils in Brucellosis.
    Moreno E; Barquero-Calvo E
    Microbiol Mol Biol Rev; 2020 Nov; 84(4):. PubMed ID: 33055283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal affairs: investigating the Brucella intracellular lifestyle.
    von Bargen K; Gorvel JP; Salcedo SP
    FEMS Microbiol Rev; 2012 May; 36(3):533-62. PubMed ID: 22373010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions.
    Salcedo SP; Marchesini MI; Degos C; Terwagne M; Von Bargen K; Lepidi H; Herrmann CK; Santos Lacerda TL; Imbert PR; Pierre P; Alexopoulou L; Letesson JJ; Comerci DJ; Gorvel JP
    Front Cell Infect Microbiol; 2013; 3():28. PubMed ID: 23847770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host response to Brucella infection: review and future perspective.
    Elfaki MG; Alaidan AA; Al-Hokail AA
    J Infect Dev Ctries; 2015 Jul; 9(7):697-701. PubMed ID: 26230118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1.
    Salcedo SP; Marchesini MI; Lelouard H; Fugier E; Jolly G; Balor S; Muller A; Lapaque N; Demaria O; Alexopoulou L; Comerci DJ; Ugalde RA; Pierre P; Gorvel JP
    PLoS Pathog; 2008 Feb; 4(2):e21. PubMed ID: 18266466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-Like Receptors 2 and 4 Cooperate in the Control of the Emerging Pathogen
    Arias MA; Santiago L; Costas-Ramon S; Jaime-Sánchez P; Freudenberg M; Jiménez De Bagüés MP; Pardo J
    Front Cell Infect Microbiol; 2016; 6():205. PubMed ID: 28119856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection.
    Macedo GC; Magnani DM; Carvalho NB; Bruna-Romero O; Gazzinelli RT; Oliveira SC
    J Immunol; 2008 Jan; 180(2):1080-7. PubMed ID: 18178848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bartonella and Brucella--weapons and strategies for stealth attack.
    Ben-Tekaya H; Gorvel JP; Dehio C
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23906880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.
    Gomez G; Adams LG; Rice-Ficht A; Ficht TA
    Front Cell Infect Microbiol; 2013; 3():17. PubMed ID: 23720712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.